Abstract
Treatment options for bronchial fistula (BF) after pneumonectomy are often limited and carry significant morbidity and mortality. The patient underwent right extrapleural pneumonectomy for malignant pleural mesothelioma had BF without macroscopic fistula found by bronchography. We treated this minor BF using bronchoscopy with the administration of OK-432, fibroblast growth factor basic, and fibrin glue sealant. Two weeks after this treatment, we confirmed the improvement of the fistula by bronchography. Bronchoscopic therapy for BF was useful for a small, early fistula without infection.
Similar content being viewed by others
References
Martini G, Widmann J, Perkmann R, Steger K. Treatment of bronchopleural fistula after pneumonectomy by using an omental pedicle. Chest. 1994;105:957–9.
Yokomise H, Takahashi Y, Inui K, Yagi K, Mizuno H, Aoki M, et al. Omentoplasty for postpneumonectomy bronchopleural fistulas. Eur J Cardiothorac Surg. 1994;8:122–4.
Sugarbaker DJ, Jaklitsch MT, Bueno R, Richards W, Lukanich J, Mentzer SJ, et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg. 2004;128:138–46.
Stewart DJ, Martin-Ucar AE, Edwards JG, West K, Waller DA. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations. Eur J Cardiothorac Surg. 2005;27:373–8.
Asamura H, Naruke T, Tsuchiya R, Goya T, Kondo H, Suemasu K. Bronchopleural fistulas associated with lung cancer operations. Univariate and multivariate analysis of risk factors, management, and outcome. J Thorac Cardiovasc Surg. 1992;104:1456–64.
Opitz I, Kestenholz P, Lardinois D, Muller M, Rousson V, Schneiter D, et al. Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2006;29:579–84.
Lois M, Noppen M. Bronchopleural fistulas: an overview of the problem with special focus on endoscopic management. Chest. 2005;128:3955–65.
Puskas JD, Mathisen DJ, Grillo HC, Wain JC, Wright CD, Moncure AC. Treatment strategies for bronchopleural fistula. J Thorac Cardiovasc Surg. 1995;109:989–95 (discussion 95–96).
Jessen C, Sharma P. Use of fibrin glue in thoracic surgery. Ann Thorac Surg. 1985;39:521–4.
Fleisher AG, Evans KG, Nelems B, Finley RJ. Effect of routine fibrin glue use on the duration of air leaks after lobectomy. Ann Thorac Surg. 1990;49:133–4.
Imai K, Matsuzaki I, Minamiya Y, Saito H, Yoshida S, Hirayama K, et al. Postoperative bronchial stump fistula after lobectomy: response to occlusion with polyglycolic acid mesh and fibrin glue via bronchoscopy. Gen Thorac Cardiovasc Surg. 2011;59:771–4.
Steenfos HH. Growth factors and wound healing. Scand J Plast Reconstr Surg Hand Surg. 1994;28:95–105.
Nugent MA, Iozzo RV. Fibroblast growth factor-2. Int J Biochem Cell Biol. 2000;32:115–20.
Garcia-Polo C, Leon-Jimenez A, Lopez-Campos JL, Arnedillo A, Gonzalez-Moya E, Fernandez-Berni JJ, et al. Endoscopic sealing of bronchopleural fistulas with submucosal injection of a tissue expander: a novel technique. Can Respir J. 2010;17:e23–e2424.
Fasching G, Sinzig M. OK-432 as a sclerosing agent to treat wound-healing impairment. Eur J Pediatr Surg. 2007;17:431–2.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest.
Ethical approval
The facility’s ethics review board accepted the application for unapproved usage of insured drugs in the form of a post-process under control number 202005-217.
Informed consent
Informed consent was obtained from the patient.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kondo, N., Hashimoto, M., Takuwa, T. et al. Treatment of bronchial fistula after extraplural pneumonectomy using flexible bronchoscopy with the administration of OK432, fibroblast growth factor basic and fibrin glue sealant. Gen Thorac Cardiovasc Surg 68, 1562–1564 (2020). https://doi.org/10.1007/s11748-020-01349-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-020-01349-8